The World Health Organization (WHO) Revises Strategy Against Hepatitis B – Lowering Treatment Thresholds to Increase Access
The World Health Organization (WHO) has revised its strategy against hepatitis B (HBV). The threshold for treatment has been lowered by dramatically relaxing the medical standards for which treatment is deemed necessary. In other words, it is recognized that it is impossible to end hepatitis without increasing the number of patients receiving treatment. Not only […]
Expanding Treatment Eligibility: WHO’s Revised Strategy Against Hepatitis B
The World Health Organization (WHO) has revised its strategy against hepatitis B (HBV). The threshold for treatment has been lowered by dramatically relaxing the medical standards for which treatment is deemed necessary. In other words, it is recognized that it is impossible to end hepatitis without increasing the number of patients receiving treatment. Not only […]
Breakthroughs in Dyslipidemia Treatment: Promising New Drug Candidates Revealed at ACC.24
#74% reduction in triglyceride levels (floxasiran)#Reduce neutral fat levels by half (olesarsen)#Reduction of LDL cholesterol level by more than half (Rerodalcibef) During the American College of Cardiology’s annual scientific session (ACC.24), new drug candidates considered the next generation of dyslipidemia were revealed. In patients with severely elevated triglyceride levels, flozasiran reduced triglyceride levels by an […]
New Multidisciplinary Approach for Tuberculous Pericarditis Diagnosis and Treatment: A Breakthrough Study
The results of successful diagnosis and treatment of tuberculous pericarditis using a new multidisciplinary approach have been published in an international academic journal. The research team led by Professors Mihyang Jeong (corresponding author) of the Department of Cardiovascular Medicine and Juhyeon Oh (co-first author) of the Department of Nuclear Medicine of the Cardiocerebrovascular Hospital, Seoul […]
Next-Generation Dyslipidemia Drugs Show Significant Reduction in Lipid Levels at ACC.24 Conference
#74% reduction in triglyceride levels (floxasiran)#Reduce neutral fat levels by half (olesarsen)#Reduction of LDL cholesterol level by more than half (Rerodalcibef) During the American College of Cardiology’s annual scientific session (ACC.24), new drug candidates considered the next generation of dyslipidemia were revealed. In patients with severely elevated triglyceride levels, flozasiran reduced triglyceride levels by an […]
Long-Term Follow-Up Results of PSA Testing for Prostate Cancer: Controversy Persists
While controversy continues over the effectiveness of the prostate-specific antigen (PSA) test for detecting prostate cancer, long-term follow-up results over 15 years have been only half successful. Although a decrease in mortality was observed in PSA testers, there was little difference in the absolute number of deaths, so controversy over its effectiveness is expected to […]
Dong-A ST Unveils Preclinical Results of SHP1 Allosteric Inhibitor and Immunotherapy Drug ‘DA-4511’ at the AACR
Dong-A ST announces preclinical results of the SHP1 allosteric inhibitor and immunotherapy drug ‘DA-4511’ at the AACR. Dong-A ST (CEO and President Kim Min-young) will present SHP1 allosteric inhibitor and immunotherapy drug ‘DA-4511’ at the ‘American Association for Cancer Research (AACR 2024)’ held in San Diego, California, USA from the 5th to the 10th. It […]
After the meeting with President Park Dan, there was a sniping that there was no future for medical care in Korea…foreshadowing repercussions in the medical field.
As the meeting between President Seok-yeol Yoon and Chairman Dan Park of the Emergency Response Committee of the Korean Medical Residents Association took place, expectations were raised whether this could be the beginning of resolving the conflict between the government and the medical community over the expansion of medical school seats. However, after the meeting, […]
High Sodium Intake Among Heart Disease Patients Exceeds Recommendations: Study Findings
An analysis of 3,100 heart disease patients showed that 89% exceeded the recommended daily sodium intake of 1,500 mg. Since these people were found to consume double the recommended amount on average, researchers believe that a simpler method of controlling sodium content in various foods is needed, particularly for people with cardiovascular disease. The results […]
Reducing Sitting Time Can Lower Blood Pressure: Study Shows
Research has shown that reducing time spent sitting can lower blood pressure. By reducing sitting time by about 30 minutes a day, systolic blood pressure dropped to 6.68 mmHg. The results of a study conducted by researchers including Dori Rosenberg of the Kaiser Permanente Washington Health Research Institute in the United States on “The correlation […]
